Application of 18F-FDG PET/MR in the diagnosis and treatment of non-small cell lung carcinoma / 中华核医学与分子影像杂志

18F-fluorodeoxyglucose(FDG) PET/MR has been more and more widely used in non-small cell lung cancer (NSCLC). Compared with PET/CT, PET/MR has more advantages, such as higher contrast resolution of soft tissues, less radiation dose and providing physicians with more functional parameters. This article summarizes the application status of 18F-FDG PET/MR in NSCLC in terms of diagnosis, staging, restaging, and prognosis.